1 January 2020 in Medical Dosimetry
26 April 2024 in Journal of Applied Clinical Medical Physics
Purpose: Skin collimation is a useful tool in electron beam therapy (EBT) to decrease the penumbra at the field edge and minimize dose to nearby superficial organs at risk (OARs), but manually fabricating these collimation devices in the clinic to conform to the patient's anatomy can be a difficult and time intensive process. This work compares two types of patient‐specific skin collimation (in‐house 3D printed and vendor‐provided machined brass) using clinically relevant metrics.Methods: Attenuation measurements were performed to determine the thickness of each material needed to adequately shield both 6 and 9 MeV electron beams. Relative and absolute dose planes at various depths were measured using radiochromic film to compare the surface dose, flatness, and penumbra of the different skin collimation materials.Results: Clinically acceptable thicknesses of each material were determined for both 6 and 9 MeV electron beams. Field width, flatness, and penumbra results between the two systems were very similar and significantly improved compared to measurements performed with no surface collimation.Conclusion: Both skin collimation methods investigated in this work generate sharp penumbras at the field edge and can minimize dose to superficial OARs compared to treatment fields with no surface collimation. The benefits of skin collimation are greatest for lower energy electron beams, and the benefits decrease as the measurement depth increases. Using bolus with skin collimation is recommended to avoid surface dose enhancement seen with collimators placed on the skin surface. Ultimately, the appropriate choice of material will depend on the desire to create these devices in‐house or outsource the fabrication to a vendor.
27 May 2025 in Biomedical Physics & Engineering Express
Minibeam radiation therapy (MBRT) is a promising treatment technique in the early stages of clinical use. In this work, two hexagonal minibeam collimators were designed, fabricated, and validated using film measurements and Monte Carlo simulations. Film and Monte Carlo results demonstrated strong agreement, with the greatest agreement near the beam central axis. One of the previously validated MBRT collimators was then modified to allow for dose calculations on a mouse cone beam computed tomography (CBCT) dataset, and a MBRT dose distribution was preserved in the animal dataset. This validated system can be used in future cell and small animal studies to further explore MBRT in a preclinical setting.
24 January 2020 in British Journal of Radiology
Proton minibeam therapy (PMBT) is a form of spatially fractionated radiotherapy wherein broad beam radiation is replaced with segmented minibeams—either parallel, planar minibeam arrays generated by a multislit collimator or scanned pencil beams that converge laterally at depth to create a uniform dose layer at the tumor. By doing so, the spatial pattern of entrance dose is considerably modified while still maintaining tumor dose and efficacy. Recent studies using computational modeling, phantom experiments, in vitro and in vivo preclinical models, and early clinical feasibility assessments suggest that unique physical and biological attributes of PMBT can be exploited for future clinical benefit. We outline some of the guiding principle of PMBT in this concise overview of this emerging area of preclinical and clinical research inquiry.
20 May 2026 in Frontiers in Oncology
Introduction: Proton dose driven continuous scanning (DDCS) is a form of proton pencil beam scanning (PBS) in which the beam may remain on during transitions between successive spots. Mayo Clinic Florida (MCF) is preparing to commission a synchrotron-based proton therapy system designed for DDCS, incorporating novel irradiation control features. Given the novelty and complexity of this system, a systematic risk-based analysis was performed to inform upcoming commissioning strategies. Methods: A prospective risk analysis was conducted using the American Association of Physicists in Medicine (AAPM) Task Group 100 (TG 100) framework. A comprehensive process map of the DDCS irradiation control workflow was developed. Failure modes and effects analysis (FMEA) was performed to identify potential delivery system failure modes and to score each failure mode based on occurrence, severity, and lack of detectability. Targeted mitigation and commissioning strategies were then developed to address the highest-risk items. Results: Twenty-nine delivery system failure modes were identified. The highest-risk failure modes were specific to DDCS operation. Targeted commissioning strategies were defined, including scan path measurement and modeling, validation of move and flap dose, dose monitor collection efficiency testing, spot position monitor performance evaluation, and verification of control system intervention behavior. Incorporation of these strategies into the commissioning plan reduced the mean RPN by more than 50%. Discussion: This work provides a detailed description of the MCF proton DDCS irradiation control system and uses a TG 100 based approach for identifying system-specific risks. As new systems incorporate technologies for which limited guidance exists, institutions must perform their own risk analyses to determine appropriate quality management strategies.
8 October 2026 in Biology of Sex Differences
Background: Radiation-induced heart disease (RIHD) may develop months to years following radiation therapy for cancers near the heart such as lung or breast cancer. Several mouse models of RIHD exist to study the pathogenesis of disease, but to our knowledge no studies have examined whether sex differences exist in RIHD in mice. Methods: Female and male BALB/cJ mice received a single whole-heart dose of 22 Gy (Gy) radiation via a C5 collimator vs. sham controls that received 0 Gy, anesthesia and were placed in the X-ray machine for the same length of time. Endpoints were examined at 24 h (innate), day 10 (acute) and day 35 (chronic) post irradiation. Results: Females and males developed dsDNA breaks from radiation at day 10 but females had more damage than males ( p < 0.001). Vessel area and wall thickness were increased by radiation at day 10 and 35 but vessel area was greater in irradiated males than females at day 35 ( p = 0.003). Bulk RNA sequencing of the heart at day 10 revealed that females and males developed similar gene pathway responses to radiation by upregulating cellular repair pathways and developing mitochondrial dysfunction. However, females upregulated the master regulator of mitochondrial function, Pgc1α ( p = 0.0001), suggesting possible improved mitochondrial repair in females. By day 35, females developed mild cardiomyopathy while males developed myocardial and perivascular fibrosis and inflammatory dilated cardiomyopathy (iDCM). Conclusions: We observed sex differences in most cardiac parameters that we examined following radiation exposure. BALB/c males exposed to 22 Gy radiation developed iDCM by day 35 while females developed mild cardiomyopathy. Further research is needed to better understand mechanisms driving sex differences in RIHD using translational animal models.